Lonza Group AG Sustainability Reports
Lonza Group AG operates as a contract development and manufacturing organization (CDMO) that provides services and products to the pharmaceutical, biotech, and nutrition industries. The company specializes in the development and scalable manufacture of active pharmaceutical ingredients, biologics, and cell or gene therapies.
Sector: Manufacturing
Country: Switzerland
Exchange: SIX Swiss Exchange
LEI: 549300EFW4H2TCZ71055
FIGI: BBG001SDFZX8
27 reports from 2006 to 2025
